SecurityHOLX / Hologic, Inc.
InstitutionBridgewater Associates, LP
ManagerRay Dalio, Bob Prince
Shares0
Value $ 0
Related 436440AB7 / Hologic, Inc. 2% Bond Due 12/15/2037
436440AG6 / Hologic, Inc. 2% Bond Due 12/15/2043
436440AC5 / Hologic, Inc. 2% Bond Due 3/1/2042

Bridgewater Associates, LP closes position in HOLX / Hologic, Inc.

August 13, 2018 - Bridgewater Associates, LP has filed a 13F-HR form disclosing ownership of 0 shares of Hologic, Inc. (NASDAQ:HOLX) with total holdings valued at $0 USD as of June 30, 2018. Bridgewater Associates, LP had filed a previous 13F-HR on May 15, 2018 disclosing 20,164 shares of Hologic, Inc. at a value of $753,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.

Other investors with closed positions include Wexford Capital Lp, Babson Capital Management Llc, Nomura Holdings Inc, Weiss Asset Management LP, and Dynamic Technology Lab Private Ltd.

Hologic, Inc. has declared a standard industrial code (sic) of 3844 which is the "X-Ray Apparatus and Tubes and Related Irradiation Apparatus" industry. Bridgewater Associates, LP's top industries are "Printing, Publishing, And Allied Industries" (sic 27), "Rubber And Miscellaneous Plastics Products" (sic 30), and "Stone, Clay, Glass, And Concrete Products" (sic 32).

Bridgewater Associates, LP closes  position in HOLX / Hologic, Inc.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR HOLOGIC COM 436440101 0 -100.00 0 -100.00 -753 0
2018-03-31 13F-HR HOLOGIC COM 436440101 20,164 753 753 0
2016-06-30 13F-HR HOLOGIC COM 436440101 0 -100.00 0 -100.00 -1,825 0
2016-03-31 13F-HR HOLOGIC COM 436440101 52,900 0.00 1,825 1,825 0
2015-12-31 13F-HR HOLOGIC COM 436440101 0 -100.00 0 -100.00 -845 0
2013-06-30 13F-HR HOLOGIC COM 436440101 43,800 845

Related SEC Filings

HOLX / Hologic, Inc. / Capital World Investors - SC 13G/A (Passive Investment)

2018-10-10 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Hologic, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 436440101 (CUSIP Number) September 28, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi (1-0)

HOLX / Hologic, Inc. / Capital World Investors - SC 13G/A (Passive Investment)

2018-10-10 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Hologic, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 436440101 (CUSIP Number) September 28, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi (1-0)

HOLX / Hologic, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) HOLOGIC INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 436440101 (CUSIP NUMBER) December 31, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1.

HOLX / Hologic, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) HOLOGIC INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 436440101 (CUSIP NUMBER) December 31, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1.

HOLX / Hologic, Inc. / Capital World Investors - SC 13G (Passive Investment)

2018-02-16 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Hologic, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 436440101 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page sha

Related News Stories

Women Health a Prime Concern Worldwide: 3 Stocks in Focus

2018-09-28 zacks
Over the last few years, the ongoing debate about the effect of women’s health improvements on economic development is finally being taken as a matter of utmost relevance. However, the gap between words and action is still obvious as apparent from women of emerging countries whose limited or almost no access to education and employment make them extremely susceptible to life-threatening ailments. (15-0)

Hologic's Focal Therapeutics Buyout to Boost Breast Health Arm

2018-09-27 zacks
Hologic, Inc. (HOLX - Free Report) signed a definitive agreement to acquire Focal Therapeutics. The deal, valued $125 million, will widen the Breast Health product suite. Also, the buyout will strengthen the company’s position in the breast conserving surgery market. (2-0)

Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2018 Update

2018-09-03 seekingalpha
Glenview Capital Management's 13F portfolio value decreased from $17.10B to $14.66B this quarter. The number of positions decreased from 52 to 49. (93-1)

Hologic (HOLX) Down 4.8% Since Last Earnings Report: Can It Rebound?

2018-08-30 zacks
It has been about a month since the last earnings report for Hologic (HOLX - Free Report) . Shares have lost about 4.8% in that time frame, underperforming the S&P 500. (1-0)

Sleepy Summer? Chapter 2. Not For These Stocks. Check 'Em Out

2018-08-21 seekingalpha
Market “Leaders” have well-behaved prices, but there are quality outlier-priced stocks in several groups. We reveal some of them here with quick-survey methods (Reward~Risk maps). (15-0)



CUSIP: 436440101